Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care

References

• Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317:371–378.
   PubMed Web of Science ®Google Scholar
• Heinemann L, Freckmann G, Ehrmann D, et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018;391(10128):1367–1377.
   PubMed Web of Science ®Google Scholar
• J, Petruzelkova LGrunberger G, et al. Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study. Diabetes Care. 2020;43(1):37–43. [In Press].
   Google Scholar
• Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388:2254–2263.
   PubMed Web of Science ®Google Scholar
• Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167:365–374.
   PubMed Web of Science ®Google Scholar
• Haak T, Hanaire H, Ajjan R, et al. Use of flash glucose sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes. Diabetes Ther. 2017;8:573–586.
   PubMed Web of Science ®Google Scholar
• Haak T, Hanaire H, Ajjan R, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1):55–73.
   PubMed Web of Science ®Google Scholar
• Vigersky RA, Fonda SJ, Chellappa M, et al. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012;35(1):32–38.
   PubMed Web of Science ®Google Scholar
• Al Hayek AA, Robert AA, Al Dawish MA. Evaluation of FreeStyle Libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes. 2017 Dec;10:117955141774695.
   Web of Science ®Google Scholar
• Al Hayek AA, Al Dawish MA. The potential impact of the FreeStyle Libre flash glucose monitoring system on mental well-being and treatment satisfaction in patients with type 1 diabetes: a prospective study. Diabetes Ther. 2019 Aug;10(4):1239–1248.
   PubMed Web of Science ®Google Scholar
• Paris I, Henry C, Pirard F, et al. The new FreeStyle Libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year. Endocrinol Diabetes Metab. 2018;1:e00023.
   PubMedGoogle Scholar
• Oskarsson P, Antuna R, Geelhoed-Duijvestijn P, et al. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial. Diabetologia. 2018;61(3):539–550.
   PubMed Web of Science ®Google Scholar
• Nathanson D, Svensson A-M, Miftraj M, et al. Effect of flash glucose monitoring on glycaemic control in adults with type 1 diabetes: a nationwide, longitudinal observational study. Abstract presented at the 55th Annual Meeting of the European Association for the Study of Diabetes; 2019 September 16–20; Barcelona (Spain).
   Google Scholar
• Charleer S, De Block C, Van Huffel L, et al. Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study. Diabetes Care. 2020;43(2):389–397.
   PubMed Web of Science ®Google Scholar
• Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care. 2019;7(1):e000809.
   PubMed Web of Science ®Google Scholar
• Fokkert MJ, Damman A, van Dijk PR, et al. Use of FreeStyle Libre flash monitor register in The Netherlands (FLARE-NL1): patient experiences, satisfaction, and cost analysis. Int J Endocrinol. 2019;2019:1–6. Article ID 4649303.
   PubMed Web of Science ®Google Scholar
• Fokkert MJ, van Dijk PR, Edens MA, et al. Performance of the FreeStyle Libre flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2017;5:e000320.
   PubMed Web of Science ®Google Scholar
• Ish-Shalom M, Wainstein J, Raz I, et al. Improvement in glucose control in difficult-to-control patients with diabetes using a novel flash glucose monitoring device. J Diabetes Sci Technol. 2016;10:1412–1413.
   PubMedGoogle Scholar
• Messaaoui A, Tenoutasse S, Crenier L. Flash glucose monitoring accepted in daily life of children and adolescents with type 1 diabetes and reduction of severe hypoglycemia in real-life use. Diabetes Technol Ther. 2019;21(6):329–335.
   PubMed Web of Science ®Google Scholar
• Tyndall V, Stimson RH, Zammitt NN, et al. Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia. 2019;62(8):1349–1356.
   PubMed Web of Science ®Google Scholar
• Overend L, Simpson E, Grimwood T. Qualitative analysis of patient responses to the ABCD FreeStyle Libre audit questionnaire. Pract Diabetes. 2019;36(2):45–50.
   Web of Science ®Google Scholar
• Pintus D. Freestyle libre flash glucose monitoring improves patient quality of life measures in children with type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals. Diabetes Metab Syndr. 2019 Sep–Oct;13(5):2923–2926.
   PubMed Web of Science ®Google Scholar
• Deshmukh H, Wilmot EG, Bishop D, et al. The association of British clinical diabetologists UK-wide audit of Freestyle Libre use in diabetes—effect on glycaemic control. Diabetes. 2019;68(Suppl 1):299–OR.
   Web of Science ®Google Scholar
• Wilmot EG, Deshmukh H, Bishop D. The association of British clinical diabetologists’ audit of freestyle libre in diabetes in United Kingdom—effect on hypoglycaemia awareness. Diabetes. 2019 June;68(Supplement 1):959.
   Web of Science ®Google Scholar
• Al Hayek AA, Robert AA, Al Dawish MA Differences of FreeStyle Libre flash glucose monitoring system and finger pricks on clinical characteristics and glucose monitoring satisfactions in type 1 diabetes using insulin pump. Clin Med Insights Endocrinol Diabetes. 2019. [cited 2019 July 1]. doi: 10.1177/1179551419861102.
   Web of Science ®Google Scholar
• Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178–1184.
   PubMed Web of Science ®Google Scholar
• Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631–1640.
   PubMed Web of Science ®Google Scholar
• Kudva YC, Ahmann AJ, Bergenstal RM, et al. Approach to using trend arrows in the FreeStyle Libre flash glucose monitoring systems in adults. J Endocr Soc. 2018 [cited 2019 May 11];2(12):1320–1337. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243139/
   PubMed Web of Science ®Google Scholar
• Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019 June 8:pii: dci190028. [ Epub ahead of print]. DOI: 10.2337/dci19-0028
   Web of Science ®Google Scholar
• Laffel LM, Aleppo G, Buckingham BA, et al. A practical approach to using trend arrows on the Dexcom G5 CGM system to manage children and adolescents with diabetes. J Endocr Soc. 2017;1(12):1461–1476.
   PubMed Web of Science ®Google Scholar
• Edelman SV, Argento NB, Pettus J, et al. Clinical implications of real-time and intermittently scanned continuous glucose monitoring. Diabetes Care. 2018;41(11):2265–2274.
   PubMed Web of Science ®Google Scholar
• Kruger DF, Edelman SV, Hinnen DA, et al. Reference guide for integrating continuous glucose monitoring into clinical practice. Diabetes Educ. 2019;45(1 suppl):3S–20S.
   PubMed Web of Science ®Google Scholar
• Adolfsson P, Parkin CG, Thomas A, et al. Selecting the appropriate continuous glucose monitoring system – a practical approach. Eur Endocrinol. 2018;14(1):24–29.
   PubMedGoogle Scholar
• Abbott Diabetes Care. FreeStyle Libre flash glucose monitoring system. Indications and important safety information. [cited 2018 Jan 22]. Available from: https://www.freestylelibre.us/safety-information
   Google Scholar
• Abbott Diabetes Care. FreeStyle Libre flash glucose monitoring system user’s manual. [cited 2018 Jan 22]. Available from: https://freestylediabetes.co.uk/images/uploads/documents/FreeStyle_Libre_Manual.pdf
   Google Scholar
• Dexcom G6 continuous glucose monitoring systems user guide. 2020. Available from: https://s3-us-west-2.amazonaws.com/dexcompdf/G6-CGM-Users-Guide.pdf
   Google Scholar
• Medtronic Inc. Important safety information: indications, contraindications, warnings and precautions (630G). [cited 2018 Jan 21]. Available from: https://www.medtronicdiabetes.com/important-safety-information#minimed-630g
   Google Scholar
• Senseonics Inc. Eversense XL user guide. [cited 2018 Feb 1]. Available from: https://ous.eversensediabetes.com/wp-content/uploads/2017/09/LBL-1202-25-101_Rev_B_EversenseXL_User_Guide_mmolL_enUK.pdf
   Google Scholar
• Karinka SA, Bailey TS, Brazg RL. Improved accuracy of 14-day factory-calibrated freestyle libre system with new glucose algorithm. Diabetes. 2019;68(Suppl1):910.
   Web of Science ®Google Scholar
• Shah VN, Laffel LM, Wadwa RP, et al. Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther. 2018;20(6):428–433.
   PubMed Web of Science ®Google Scholar
• Keenan DB, Mastrototaro JJ, Zisser H, et al. Accuracy of the enlite 6-day glucose sensor with guardian and veo calibration algorithms. Diabetes Technol Ther. 2012;14(3):225–231.
   PubMed Web of Science ®Google Scholar
• Christiansen MP, Klaff LJ, Brazg RR, et al. A prospective multicenter evaluation of the accuracy of a novel implanted continuous glucose sensor: PRECISE II. Diabetes Technol Ther. 2018;20(3):197–206.
   PubMed Web of Science ®Google Scholar
• Messer LH, Berget C, Beatson C, et al. Preserving skin integrity with chronic device use in diabetes. Diabetes Technol Ther. 2018;20(Suppl 2):S254–S264.
   PubMed Web of Science ®Google Scholar
• Dunn TC, Xu Y, Hayter G, et al. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests. Diabetes Res Clin Pract. 2018 [cited 2019 May 22];137:37–46.
   PubMed Web of Science ®Google Scholar
• Aleppo G, Laffel LM, Ahmann AJ, et al. Practical approach to using trend arrows on the Dexcom G5 CGM system for the management of adults with diabetes. J Endocr Soc. 2017;1(12):1445–1460.
   PubMed Web of Science ®Google Scholar
• Zinman B, Marso SP, Poulter NR. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61:48–57.
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther. 2013;15(3):198–211.
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): anew term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41:2275–2280.
   PubMed Web of Science ®Google Scholar
• Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open. 2013;3:e001570.
   PubMed Web of Science ®Google Scholar
• Al Shahrani A, Baraja M. Patient satisfaction and it’s relation to diabetic control in a primary care setting. J Family Med Prim Care. 2014;3:5–11.
   PubMedGoogle Scholar
• Auerbach SM, Clore JN, Kiesler DJ, et al. Relation of diabetic patients’ health-related control appraisals and physician-patient interpersonal impacts to patients’ metabolic control and satisfaction with treatment. J Behav Med. 2002;25:17–31.
   PubMed Web of Science ®Google Scholar
• Yoo HJ, An HG, Park SY, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2008;82(1):73–79.
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Skinner TC. Perceived treatment efficacy: an overlooked opportunity in diabetes care. Clin Diabetes. 2010;28(2):89–92.
   Google Scholar
• Hirsch IB, Wright EE. Using flash continuous glucose monitoring in primary care. Clin Diabetes. 2019;37(2):150–161.
   PubMedGoogle Scholar